spacer
home > ict > summer 2018 > navigating global complexities
PUBLICATIONS
International Clinical Trials

Navigating Global Complexities

Insurance is a small part of the global clinical trial process, but it can have a huge impact on the contract or clinical research company’s efforts geared towards ensuring trials proceed smoothly.

Making sure a clinical trial’s insurance policy stands up to the scrutiny of the ethics committee in each territory is essential. Inappropriate insurance documentation presented to the ethics committee meeting could delay the onset of the trial until at least their next meeting, reducing the patent exclusivity period, potentially costing millions of pounds and negatively affecting important business relationships.

Having a sound understanding of the legislation and regulations governing clinical trials in the territory where the company is testing is the best starting point.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kathryn Moon is ACII qualified and has worked in the insurance industry for over 20 years in a variety of roles including Account Broker, Project Manager, Development Manager, and Account Executive. She is currently Managing Director of the Coventry office of Gallagher – the global insurance broker, risk management services, and consulting firm – and an integral part of its UK life sciences specialism. Gallagher are also members of OBN.
spacer
Kathryn Moon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with the NASDAQ listed biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the company’s unique formulations using its proprietary in vitro models to optimise Novan’s formulations and de-risk product development.
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement